ADRENALS, PARATHYROIDS, THYMUS, PINEAL
Ed Friedlander, M.D., Pathologist
scalpel_blade@yahoo.com

No texting or chat messages, please. Ordinary e-mails are welcome.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.



Search only trustworthy HONcode health websites:

This website collects no information. If you e-mail me, neither your e-mail address nor any other information will ever be passed on to any third party, unless required by law.

This page was last modified July 5, 2010.

I have no sponsors and do not host paid advertisements. All external links are provided freely to sites that I believe my visitors will find helpful.

Cyberfriends: The help you're looking for is probably here.

Welcome to Ed's Pathology Notes, placed here originally for the convenience of medical students at my school. You need to check the accuracy of any information, from any source, against other credible sources. I cannot diagnose or treat over the web, I cannot comment on the health care you have already received, and these notes cannot substitute for your own doctor's care. I am good at helping people find resources and answers. If you need me, send me an E-mail at scalpel_blade@yahoo.com Your confidentiality is completely respected. No texting or chat messages, please. Ordinary e-mails are welcome.

DoctorGeorge.com is a larger, full-time service. There is also a fee site at www.afraidtoask.com.


If you have a Second Life account, please visit my teammates and me at the Medical Examiner's office.

Freely have you received, give freely With one of four large boxes of "Pathguy" replies.

I'm still doing my best to answer everybody. Sometimes I get backlogged, sometimes my E-mail crashes, and sometimes my literature search software crashes. If you've not heard from me in a week, post me again. I send my most challenging questions to the medical student pathology interest group, minus the name, but with your E-mail where you can receive a reply.

Numbers in {curly braces} are from the magnificent Slice of Life videodisk. No medical student should be without access to this wonderful resource.

I am presently adding clickable links to images in these notes. Let me know about good online sources in addition to these:

Freely have you received, freely give. -- Matthew 10:8. My site receives an enormous amount of traffic, and I'm still handling dozens of requests for information weekly, all as a public service.

Pathology's modern founder, Rudolf Virchow M.D., left a legacy of realism and social conscience for the discipline. I am a mainstream Christian, a man of science, and a proponent of common sense and common kindness. I am an outspoken enemy of all the make-believe and bunk that interfere with peoples' health, reasonable freedom, and happiness. I talk and write straight, and without apology.

Throughout these notes, I am speaking only for myself, and not for any employer, organization, or associate.

Special thanks to my friend and colleague, Charles Wheeler M.D., pathologist and former Kansas City mayor. Thanks also to the real Patch Adams M.D., who wrote me encouragement when we were both beginning our unusual medical careers.

If you're a private individual who's enjoyed this site, and want to say, "Thank you, Ed!", then what I'd like best is a contribution to the Episcopalian home for abandoned, neglected, and abused kids in Nevada:

I've spent time there and they are good. Write "Thanks Ed" on your check.

Help me help others

My home page
More of my notes
My medical students

Especially if you're looking for information on a disease with a name that you know, here are a couple of great places for you to go right now and use Medline, which will allow you to find every relevant current scientific publication. You owe it to yourself to learn to use this invaluable internet resource. Not only will you find some information immediately, but you'll have references to journal articles that you can obtain by interlibrary loan, plus the names of the world's foremost experts and their institutions.

Alternative (complementary) medicine has made real progress since my generally-unfavorable 1983 review. If you are interested in complementary medicine, then I would urge you to visit my new Alternative Medicine page. If you are looking for something on complementary medicine, please go first to the American Association of Naturopathic Physicians. And for your enjoyment... here are some of my old pathology exams for medical school undergraduates.

I cannot examine every claim that my correspondents share with me. Sometimes the independent thinkers prove to be correct, and paradigms shift as a result. You also know that extraordinary claims require extraordinary evidence. When a discovery proves to square with the observable world, scientists make reputations by confirming it, and corporations are soon making profits from it. When a decades-old claim by a "persecuted genius" finds no acceptance from mainstream science, it probably failed some basic experimental tests designed to eliminate self-deception. If you ask me about something like this, I will simply invite you to do some tests yourself, perhaps as a high-school science project. Who knows? Perhaps it'll be you who makes the next great discovery!

Our world is full of people who have found peace, fulfillment, and friendship by suspending their own reasoning and simply accepting a single authority that seems wise and good. I've learned that they leave the movements when, and only when, they discover they have been maliciously deceived. In the meantime, nothing that I can say or do will convince such people that I am a decent human being. I no longer answer my crank mail.

This site is my hobby, and I do not accept donations, though I appreciate those who have offered to help.

During the fifteen years my site has been online, it's proved to be one of the most popular of all internet sites for undergraduate physician and allied-health education. It is so well-known that I'm not worried about borrowers. I never refuse requests from colleagues for permission to adapt or duplicate it for their own courses... and many do. So, fellow-teachers, help yourselves. Don't sell it for a profit, don't use it for a bad purpose, and at some time in your course, mention me as author and KCUMB as my institution. Drop me a note about your successes. And special thanks to everyone who's helped and encouraged me, and especially the people at KCUMB for making it possible, and my teaching assistants over the years.

Whatever you're looking for on the web, I hope you find it, here or elsewhere. Health and friendship!

PicoSearch
  Help

More of Ed's Notes: Ed's Medical Terminology Page

Perspectives on Disease
Cell Injury and Death
Accumulations and Deposits
Inflammation
Fluids
Genes
What is Cancer?
Cancer: Causes and Effects
Immune Injury
Autoimmunity
Other Immune
HIV infections
The Anti-Immunization Activists
Infancy and Childhood
Aging
Infections
Nutrition
Environmental Lung Disease
Violence, Accidents, Poisoning
Heart
Vessels
Respiratory
Red Cells
White Cells
Coagulation
Oral Cavity
GI Tract
Liver
Pancreas (including Diabetes)
Kidney
Bladder
Men
Women
Breast
Pituitary
Thyroid
Adrenal and Thymus
Bones
Joints
Muscles
Skin
Nervous System
Eye
Ear
Autopsy
Lab Profiling
Blood Component Therapy
Serum Proteins
Renal Function Tests
Adrenal Testing
Arthritis Labs
Glucose Testing
Liver Testing
Porphyria
Urinalysis
Spinal Fluid
Lab Problem
Quackery
Alternative Medicine (current)
Preventing "F"'s: For Teachers!
Medical Dictionary

Courtesy of CancerWEB

Endocrine
Taiwanese pathology site
Good place to go to practice

Endocrine
Photo Library of Pathology
U. of Tokushima

Mediastinum (Thymus)
Photo Library of Pathology
U. of Tokushima

Endocrine
Iowa Virtual Microscopy
Have fun

Endocrine
Utah cases for path students
Juliana Szakacs MD

Tulane Pathology Course
Great for this unit
Exact links are always changing

Endocrine System
Great pathology images
Indiana Med School

Adrenal Exhibit
Virtual Pathology Museum
University of Connecticut

Endocrine
Photos, explanations, and quiz
Indiana U.

Adrenal
Nice case photos
Charam M. Ramnani MD

Endocrine
Brown Digital Pathology
Some nice cases

QUIZBANK

STUDY OBJECTIVES

Mention the normal gross and microscopic anatomy of the adrenal glands, parathyroid glands, and thymus gland. Describe their origins within individuals, and their functions.

Define hypoadrenocorticism, mention the etiologies of the chronic and acute forms, and tell what each looks like clinically. Explain hyperpigmentation in some of these patients, and tell why they are at risk for sudden death.

Describe the etiologies of Cushing's syndrome, from the most to the least common. Tell what symptoms and signs should alert you, the physician, to the possibility of Cushingism. Explain Nelson's syndrome, and why it is becoming uncommon.

Define primary hyperaldosteronism and Conn's syndrome. Distinguish these from secondary hyperaldosteronism. Tell what symptoms and signs point to excess aldosterone, and explain the danger of treating these patients with "safe" diuretics.

Describe in detail the pathogenesis of congenital adrenal hyperplasia, and distinguish the most common salt-retaining and the most common salt-wasting form. Describe the forme fruste that we now believe is very common.

Describe the behavior of carcinomas of the adrenal cortex.

Discuss pheochromocytoma and neuroblastoma with respect to their names, locations, etiologies, catecholamine production, gross and microscopic appearances, clinical picture, and prognosis. Mention the "primitive neuroectodermal tumors" that look like neuroblastomas, and describe "spontaneous cures" of neuroblastoma. Provide an educated guess of how many of your classmates had a "neuroblastoma" at birth.

Describe in some depth the prevalence, etiologies, symptoms, signs and treatment of hyperparathyroidism. Explain how to tell parathyroid hyperplasia from parathyroid adenoma, and why anyone cares. Describe how and when hypoparathyroidism develops, why it is serious, and how to recognize it.

Describe how the size of the thymus gland changes with age. Define thymic hyperplasia and thymoma, tell what they look like, and mention the diseases with which they are associated.

List the components of the important anti-oncogene deletion syndromes MEN I, IIa, and IIb.

MAINTAIN A HIGH INDEX OF SUSPICION FOR ENDOCRINE DISEASE. This lecture ought to scare you.

Adrenal gland
"Pathology Outlines"
Nat Pernick MD, great site

Adrenal Histology
Ed's Histology Notes

Normal adrenal
Find it!
WebPath Photo

Adrenal histology
Point and click
WebPath Photo

Normal adrenals

WebPath Photo

Normal adrenals

WebPath Photo

THE ADRENAL CORTEX: "An organ essential to life." Pathology of the adrenal cortex: Arch. Path. Lab. Med. 132: 1263, 2008.

{11204}      adrenal and its nerve, normal
{11207}      adrenal and its nerve, normal
{11210}      adrenal and its nerve, histology, normal
{15035}      normal adrenal gland, showing zones (can you figure them out?)


Androstenedione (?)

{49431}      hyperplasia of adrenal cortex, etiology undisclosed
{09217}      adrenal cortical hyperplasia, etiology unknown

CONGENITAL ADRENAL HYPOPLASIA

Adrenal -- cytomegalic fetal cortex
Beckwith-Wiedemann
Wikimedia Commons

ECTOPIC ADRENAL CORTICAL TISSUE (sometimes ectopic adrenal medulla too)

HYPOADRENOCORTICISM ("Addisonism", etc.): Insufficient glucocorticoid (and usually insufficient mineralocorticoid) production. Reviews Lancet 361: 1881, 2003; NEJM 360: 2328, 2009.

{09223}      adrenal tuberculosis, gross
{25399}      tuberculosis of adrenal, histology
{27257}      tuberculosis of adrenal, histology

Adrenal atrophy in
treated addisonism
KCUMB Team

TB of the adrenal

WebPath Photo

{25394}      adrenal cortical atrophy (key says "hypoplasia", I doubt this)
{24607}      adrenal amyloidosis, gross
{15960}      cytomegalic inclusion disease, adrenal
{37216}      adrenal leukodystrophy ("Lorenzo's oil") case, gross brain
{37218}      adrenal leukodystrophy case, gross brain
{37221}      adrenal leukodystrophy case, histology brain
{37224}      adrenal leukodystrophy case, gross adrenal
{37225}      adrenal leukodystrophy case, histology adrenal

Adrenal amyloidosis

WebPath Photo

Adrenals
Atrophic, normal, hyperplastic
WebPath Photo

      NOTE: Hollywood is Hollywood. Evidence that "Lorenzo's oil" benefits adrenoleukodystrophy patients remains "anecdotal" (Brain & Dev. 14: 409, 1992); it failed controlled studies miserably (NEJM 329: 745 & 801, 1993; NEJM 330: 1904, 1994; Ann. Neuro. 34: 121 & 169, 1993), and poisons platelets (NEJM 328: 1126, 1993; Am. J. Hem. 44: 290, 1993; J. Inh. Metab. Dis. 17: 628, 1995) and (at least sometimes) natural-killer lymphocytes (J. Inh. Metab. Dis. 18: 101, 1995). We've now got two series of dead adrenoleukodystrophy patients who were treated in life with Lorenzo's oil. It turns out that the stuff doesn't even cross the blood-brain barrier, which is probably why it doesn't work (Neuroch. Res. 19: 1073, 1995; Ann. Neuro. 36: 741, 1995). Yet another massive failure: J. Neurol. Neurosurg. Psych. 67: 290, 1999. Interest continues, and a study from Hopkins (Arch. Neuro. 62: 1073, 2005) that claimed success in preventing lesions in asymptomatic boys had no controls and also included other dietary alterations.

    ACTH DEFICIENCY ("secondary hypoadrenocorticism")

      These patients have almost always lost their adenohypophysis and have "panhypopituitarism". (Treat the whole person.... Caring for a little pituitary dwarf? Don't get focused on the height so that you forget the likely adrenal insufficiency.... J. Clin. End. Metab. 81: 1693, 1996). Less often, they have selective, presumably autoimmune, loss of the ACTH-producing cells: Arch. Int. Med. 152: 1705, 1992.

    Clinical picture:

      "Addisonian" patients show weakness, nausea, and weight loss, and are usually hypotensive (* 110/70 or less) and have other complaints. Like most endocrine patients, the problems are likely to appear "emotional".

      In primary hypoadrenocorticism, the skin and buccal mucosa will usually be hyperpigmented, due to increased ACTH (MSH?) -- also look at freckles, nipples, palmar creases, old scars.

      Lab studies typically show hyponatremia, hyperkalemia, metabolic acidosis, hypoglycemia, low serum cortisol, low urinary 17-OH-steroids, and (most important) failure to respond to various "stimulation tests" by increasing cortisol output.

      It is common for these patients to die suddenly and unexpectedly before anyone thinks of adrenocortical insufficiency. This still happens (Br. Med. J. 312: 1085, 1996).

      * Osteoporosis is severe in post-menopausal women with Addisonism, because of loss of adrenal androgens.

      Replacement therapy is life-saving. (And get your patient a syringe of cortisol and an ID bracelet.)

        * Some women feel better and have better sexuality if they get some DHEA. Makes sense. Why? (NEJM 341: 1013, 1999).

{09371}      Addison's disease; pigmentation and vitiligo (mother and daughter)
{09372}      Addison's disease, face
{09373}      Addison's disease, buccal pigmentation
{49438}      Addison's disease, pigmentation
{49439}      Addison's disease, pigmentation
{49440}      Addison's disease, atrophy of the adrenal gland

    SELECTIVE HYPOALDOSTERONISM is rarely due to primary disease of the adrenal cortex. (Clinicians talk about "hyporeninemic hypoaldosteronism".)

      Much more often, the problem is really that the JGA is not producing renin (REE-nin, remember?). Usually the problem is diabetic arteriolar disease (no surprise); less often, it is one of the diseases of the renal tubules and/or interstitium.

      * These patients have type IV renal tubular acidosis, exhibit normal response to ACTH stimulation testing, and need a prescription for oral 9α-fludrocortisone.

    ACUTE HYPOADRENOCORTICISM ("adrenal apoplexy", "Addisonian crisis"): Sudden collapse, often fatal (the mechanisms are not fully understood, but it involves opening of the peripheral vasculature and shock with high cardiac output; consider giving any such patient glucocorticoid: Arch. Surg. 128: 673, 1993.)

      PLEASE DO NOT MISS THIS ONE.

      It may result from undiagnosed adrenal insufficiency (iatrogenic, or patients stressed by infection, surgery, or treatment of concurrent myxedema; see for example J. Traum. 32: 94, 1992), or from known Addison's disease when extra glucocorticoids are not provided during stress.

      WATERHOUSE-FRIDERICHSEN SYNDROME ("adrenal apoplexy") features hemorrhage, fibrin thrombi, and sometimes necrosis in the adrenals in a setting of sepsis. It's not clear whether death is due to adrenal shutdown, but it's not helping.

        This occurs when there is overwhelming sepsis with hemorrhage into, and destruction of, the adrenals. Patients develop purpura, shock, and die in a few hours.

        The etiologic agent is classically the meningococcus, though staphylococci (possible new WF-producing strain NEJM 353: 1245, 2005), pneumococci, and H. influenzae are other important causes (J. Clin. Path. 57: 208, 2004).

        W-F is not rare, and is often overlooked. One group suggests that if your patient in shock does NOT have elevated serum cortisol, he or she presumably has W-F. Draw blood, then give 200 or 300 mg of hydrocortisone (West. J. Med. 150: 582, 1989). Another protocol, for anybody who's septic: Am. J. Med. 98: 266, 1995.

      * Expect the unexpected. A lady dies because toluene inhalation somehow produces adrenal necrosis: J. Tox. 36: 365, 1998.

{24606}      Waterhouse-Friderichsen adrenal, gross
{09224}      adrenal hemorrhage, consistent with Waterhouse Friderichsen
{07570}      adrenal hemorrhage, gross, consistent with Waterhouse-Friderichsen syndrome

Waterhouse-Friderichsen
Patient photo
WebPath Photo

Waterhouse-Friderichsen
Cortex blood / necrotic, medulla (blue) spared
KCUMB Team

Waterhouse-Friderichsen

WebPath Photo

Waterhouse-Friderichsen

WebPath Photo

CUSHING'S SYNDROME: too much glucocorticoid. Review NEJM 332: 791, 1995.

    Etiologies, from most to least common

      1. IATROGENIC (the most common cause nowadays, preventable in part by giving "alternate-day" glucocorticoid therapy). Of course, the adrenals will be atrophic if glucocorticoids were administered, hyperplastic if ACTH was administered.

      2. ACTH-PRODUCING PITUITARY LESION, usually a basophilic microadenoma ("Cushing's disease", "pituitary Cushingism")

        The adrenals will usually be diffusely enlarged, but may be nodular, often with one or more large nodules (CT scanners take note -- a single "adenoma" does NOT necessarily rule out the need for pituitary surgery).

        "Nelson's syndrome" -- rapid enlargement of the pituitary adenoma leading to hyperpigmentation, blindness and death -- followed adrenalectomy in many of these patients. (Why? It still happens -- sometimes the only way to relieve Cushingism is to remove the adrenals.)

      3. ADRENAL CORTICAL ADENOMA OR CARCINOMA ("adrenal Cushingism"); the tumor may be primary, or an autonomous adrenal tumor may develop after years of "pituitary Cushingism")

      4. ACTH- (OR CRH-) PRODUCING CANCERS OF OTHER ORGANS: oat-cell carcinoma (very well-known), bronchial and thymic carcinoids (rather common; S. Med. J. 87: 855, 1994; Mayo Clin. Proc. 69: 594, 1994), medullary thyroid carcinoma, islet cell cancer; other APUDomas. Full-blown Cushingism is rare in oat cell patients, only because they don't live long enough.... Again, the hyperplasia is usually diffuse but may be nodular.

{49441}      looks like an oat cell case; adrenal cortex is hyperplastic, and bears a metastasis

        * Urocortin is a hormone widely distributed in the nervous system, with CRH-like activities; it is presently in search of a disease. Both CRF and urocortin are potent anorectic agents. The newly-discovered "urocortin 3" is also called "stresscopin". The truly hardcore can see J. Clin. Endo. Metab. 90: 4671, 2005.

      5. Really "primary" adrenal hyperplasia (not due to excess ACTH):

      • "primary pigmented nodular adrenocortical hyperplasia", a "newly discovered disease" that is part of the autosomal dominant Carney complex (along with weird tumors and a paradoxical response to the dexamethasone suppression test: Ann. Int. Med. 131: 585, 1999); it is now well-characterized genetically (J. Clin. Endo. Metab. 91: 1943, 2006).
      • Circulating antibodies against the ACTH receptor (analogous to Graves disease) can occasionally stimulate the gland into hyperactivity. Call a surgeon.
      • * Macronodular hyperplasia with marked adrenal enlargement. Arch. Path. Lab. Med. 123: 167, 1999.
      • Future pathologists: Don't get excited over a lumpy adrenal. Many people have a few adrenal nodules, including a few pigmented ones.

      * Genetic syndrome with too many cortisol receptors, low plasma cortisol: J. Clin. Endo. Metab. 85: 14, 2000.

    * 6. Cushingism with a burst of cortisol after eating: inappropriate expression of GIP receptors on the adrenal cortex / adrenal adenoma (NEJM 327: 974, 1992; J. Clin. End. Metab. 81: 3168, 1996; J. Clin. Endo. Metab. 86: 583, 2001). There are other aberrant receptor problems as well: J. Clin. Endo. Metab. 88: 416, 2003.

    * 7. Recurrent cushingism of pregnancy: Nobody understands it; the adrenal cortex must over-respond to some non-ACTH hormone made during gestation J. Clin. End. Metab. 81: 15, 1996; Clin. Endo. 54: 277, 2001.

Both Cushing's disease and glucocorticoid-secreting adenomas are most common in women ages 15 to 45, but can hit anybody, anytime. (* Cushingism in kids and teens: NEJM 331: 629, 1994).

Symptoms and signs that should alert you to possible Cushingism:

  • truncal obesity with "buffalo hump" ("upper trunk fat") and "moon face"

  • increased appetite

  • insomnia and mental changes (* Cushing's psychosis seems to be treatable using RU486, i.e., mifepristone, better known as "the abortion pill", a fact that held up its use in the U.S. for years; at high doses it is an effective cortisol antagonist: Ann. Int. Med. 114(2): 143, 1991; review NEJM 329: 404, 1993; it is now mainstream J. Clin. Endo. Metab. 86: 3568, 2001).

  • vascular and connective tissue changes: thinning of the dermis (helps you spot it: Arch. Int. Med. 154: 777, 1994), bruisability, striae ("purple stripes"), very poor healing, purpura -- * look at old band-aid sites)

  • high blood pressure

  • glucose intolerance (diabetes, with complications)

  • osteoporosis (loss of the bone substance)

  • loss of normal circadian rhythm of cortisol secretion (this is important, because it helps you and the lab make the diagnosis)

  • other: acne, cellulitis, edema, gastric ulcers, hirsutism, acne, oligomenorrhea (scanty menstrual flow), hypokalemia, muscle wasting, ringworm

{09367}      Cushingism, face
{09370}      Cushingism, face
{16109}      Cushing's syndrome
{16110}      Cushing's syndrome
{16112}      Cushing's syndrome "before"
{16111}      Cushing's syndrome "after"
{49426}      Cushingism, 40 y/o patient
{49427}      Cushingism
{49428}      Cushingism, hyperplastic adrenal cortex

    * Future pathologists: Heavy negative feedback on pituitary basophilic ACTH-producing cells produces "Crooke's hyaline change".

PRIMARY HYPERALDOSTERONISM ("low-renin hyperaldosteronism"): too much mineralocorticoid (review: Postgrad. Med. 95(4): 199, March 1994; NEJM 339: 1820, 1999; Lancet 353: 1341, 1999; Surg. Clin. N.A. 84: 887, 2004; Lancet 371: 1921, 2008)

    This results from "idiopathic" adrenal hyperplasia, or an adrenal adenoma.

    This is important as a cause of surgically-correctable high blood pressure. Maybe 0.5% of hypertensives have primary hyperaldosteronism. The most recent work (Lancet 2008) uses the retrospectoscope to show that Conn's is probably not so common as has recently been claimed, but still an important concern.

    Classically, patients exhibit hypokalemia, alkalosis, and low renin, and a failure of plasma aldosterone levels to increase significantly when the patient goes from supine to standing position.

    Surprisingly, these patients do not have edema. (The effects of aldosterone in hanging onto body salt is overridden by atrial natriuretic peptide.)

      Low potassium is likely to cause muscle weakness, and even paralysis.

      Trap: These patients can die from hypokalemia if you give them thiazide diuretics to treat their high blood pressure.

    Today, we screen by looking for the plasma aldosterone / plasma renin activity ratio. Some hypertensives have elevated levels, and many of these people will indeed have an aldosteronoma that can be removed (Am. J. Med. Sci. 324: 227, 2002); the rest will usually have hyperplastic cortices.

    The most familiar cause is an "autonomous" adrenal cortical adenoma (CONN'S SYNDROME), often very small. It produces aldosterone (rare Conn-omas produce DOC instead). You'll clinch the diagnosis by sampling aldosterone levels in the adrenal veins (J. Clin. End. Metab. 86: 1066, 2001). Surgery is curative (Ann. Surg. 219: 347, 1994; Postgrad. Med. 95(4): 199, Mar. 1994); it is now routinely done via laparoscope (review J. Urol. 169: 32, 2003).

    Adrenal cortical adenoma
    Produced Conn's
    Wikimedia Commons

      The rest of the patients have "idiopathic hyperaldosteronism", with normal or hyperplastic adrenals. These patients get spironolactone. Not surprisingly, the borderland between these and the adenomas is blurry (Surgery 106: 1161, 1990); probably it's best to operate only if the hypertension is unsuppressible medically like a Conn-oma.

        * In "Conn's caused by idiopathic hyperplasia of the zona glomerulosa", look for cords of glomerulosa-type cells creeping down into the zona fasciculata.

      A few patients have glucocorticoid-correctable hyperaldosteronism and hypertension. This is transmitted autosomal-dominant. It is now clear that the problem is a chimeric beta-hydroxylase/aldosterone synthetase gene (Nature 355: 262, 1992; Lancet 339: 1024, 1992; screening kids Arch. Dis. Child. 71: 40, 1994; J. Urol. 154: 510, 1995). Update J. Clin. Endo. Metab. 87: 3187, 2002. When the cell is told by ACTH to make cortisol, it pumps out huge amounts of aldosterone, too. (Thinkers: Giving a tiny amount of exogenous glucocorticoid solves the problem. How? If you can't answer this, go back and review your endocrine physiology.)

      * Hypertension from a mutated aldosterone receptor stuck in the "on" position: Science 289: 119, 2000.

    * Another cause is "apparent mineralocorticoid excess syndrome", a lack of 11-β-hydroxysteroid dehydrogenase type 2, which turns cortisol to cortisone in the renal tubules; cortisol ends up overstimulating the mineralocorticoid receptors. The forme fruste may be a common contributor to "idiopathic" low-renin hypertension even with normal potassium. See J. Clin. Endo. Metab. 86: 1247, 2001; Lancet 353: 1341, 1999. Yet another is a 21-deoxyaldosteronoma (J. Clin. End. Metab. 80: 737, 1995). Rarely an ovarian cancer produces aldosterone (series Arch. Int. Med. 156: 1190, 1996).

    SECONDARY ALDOSTERONISM is much more common. It is part of the picture in CHF, cirrhosis, nephrotic syndrome, Goldblatt hypertension, and other common problems.

      Don't forget Bartter's hypokalemia (vessels are insensitive to angiotensin and/or the sodium pump in the ascending loop of Henle doesn't work -- Hosp. Pract. 29(5): 103, 1994.

    Don't confuse this with salt-retaining congenital adrenal hyperplasia (see below).

CONGENITAL ADRENAL HYPERPLASIA: autosomal-recessive virilization syndromes that, in their most severe forms, affect young children.

    Deficiencies (mild or severe) of the various enzymes required to synthesize cortisol result in decreased production of cortisol and other hormones.

      This results in increased ACTH, with resulting adrenal cortical hyperplasia.

      Steroid precursors are shunted into the production of abnormally large amounts of the androgen androstenedione (ambiguous genitalia in girls, "infant Hercules" and Leydig cell nodules in boys, etc.)

    Remember these two types (there are at least six others):

      21-HYDROXYLASE DEFICIENCY (most common): no cortisol, aldosterone, or DOC, hence salt wasting. This gene is inside the HLA locus. Review J. Clin. Endo. Metab. 88: 2624, 2003.

      11-BETAHYDROXYLASE DEFICIENCY: huge amounts of DOC, causing salt retention and high blood pressure (molecular biology of the gene Proc. Nat. Acad. Sci. 90: 4552, 1993).

    Full-blown congenital adrenal hyperplasia is a devastating illness, especially for women. Mild variants of these syndromes (i.e., relatively ineffective enzymes -- especially 21-hydroxylase deficiency) are probably widespread -- causing, for example, amenorrhea in girls or hirsutism in older women.

      It's important to find these people because a little dexamethasone given daily will greatly improve the internal milieu.

      To test your female patient with amenorrhea or hirsutism, administer ACTH and measure plasma 17-hydroxyprogesterone one hour later. It will be elevated if your patient has even mild 21-hydroxylase deficiency.

{49437}      adrenogenital syndrome 2 year old girl
{24450}      adrenogenital syndrome, virilized baby girl
{49432}      11-hydroxylase deficiency, 11 month old boy

ADRENAL CORTICAL ADENOMAS

    These are round, yellow (like the adrenal cortex) nodules. (* Purists call them "nodular hyperplasia" if the surrounding cortex is at all lumpy-bumpy).

    Adrenal cortical adenomas are surprises at around 2% of autopsies and abdominal CT scans. They can cause Cushing's syndrome, Conn's syndrome, or virilization -- but the vast majority seem to produce nothing.

      They are commonly discovered on CT scans too, and clinicians are learning to ignore small adrenal masses ("incidentalomas", so long as there is no evidence of steroid or catecholamine over-production).

        About 75% of incidentalomas are adenomas; next most common is myelolipoma. The folks at Brown had a series of almost 1000 patients with incidentalomas biopsied, without one cancer (AJR 190: 1163, 2008); their surgeons also say, "Leave them alone" (Arch. Surg. 144: 465, 2009).

        * Consider screening folks with incidentalomas for Cushingism. Maybe 20% of these really are active, and contribute to hypertension, diabetes, obesity, and osteoorosis, even if the patient is not floridly Cushingoid. Common sense triumphant. See Surg. Clin. N.A. 84: 875, 2004. "Occult/subclinical Cushingism due to incidentaloma" is now a recognized entity: J. Clin. Endo. Metab. 88: 5808, 2003. NIH Consensus Conference: Ann. Int. Med. 138: 424, 2003.

        The case against fine-needling incidentalomas, made by surgeons: Surgery 142: 497, 2007.

      * Leave discussions of the arcana of these common lesions to us. This includes "spironolactone bodies" (pink scroll-like things, also found in the ZG of folks taking spironolactone), "black adenomas", and much more.

      "Adrenal cysts" seen on scans have unpredictable pathology: Cancer 101: 1537, 2004.

{09220}      adrenal cortical adenoma, gross
{20312}      adrenal cortical adenoma, gross
{49436}      adrenal cortical adenoma, gross; this one produced Conn's syndrome
{10298}      adrenal cortical adenoma
{20315}      adrenal cortical adenoma, histology
{09221}      adrenal cortical adenoma, histology
{09222}      adrenal cortical adenoma, histology
{08964}      adrenal cortical adenoma, histology (hard to tell from normal cortex)
{09052}      adrenal cortical adenoma, electron micrograph; note tubular cristae in mitochondria (spaghetti instead of lasagna)
{09375}      effect of masculinizing adrenal cortical adenoma, "before"
{09374}      effect of masculinizing adrenal cortical adenoma, "after"
{49434}      gynecomastia in five-year old boy, feminizing adrenal cortical adenoma

Adrenal cortical adenoma
This was a cushingoma
WebPath Photo

Adrenal cortical adenoma
Urbana Atlas of Pathology

Adrenal cortical adenoma
This was a connoma
WebPath Photo

Adrenal cortical adenoma

WebPath Photo

    ADRENAL MYELOLIPOMA: a metaplasia-choristoma made of bone marrow. They can be big but are generally harmless. You can see bone marrow in adrenal cortical hyperplasia too.

{25412}      adrenal myelolipoma, gross
{49443}      adrenal myelolipoma, gross
{25413}      adrenal myelolipoma, histology

Adrenal myelolipoma
Pittsburgh Pathology Cases

ADRENAL CORTICAL CARCINOMA (Am. J. Clin. Path. 105: 76, 1996; J. Urol. 169: 5, 2003)

    These are rare cancers that are often lethal. Many are are hormonally active and produce Cushing's, Conn's, and/or virilization.

      Future pathologists: These are usually obviously malignant, grossly and microscopically, with ten or more mitotic figures per high power field.

        * Another tipoff is broad fibrous bands, but you usually won't need this to know you're looking at cancer.

        The most reliable way of spotting malignancy is still the mitotic figure count; other systems have not proved very reliable (Am. J.Clin. Path. 127: 398, 2007).

          * The only real fooler is an adenoma, usually in a child under age 5, made of bizarre cells with big nuclei, but the rarity of mitotic figures indicates this is benign.

      * Mixed endocrine syndromes usually mean cancer. Adrenal tumors that feminize, or that produce androgens without glucocorticoids, are most often malignant.

      Mitotane, an analogue of the old-fashioned insecticide DDT, is the classic mainstay of therapy. (It will also destroy and scar any remaining normal adrenal gland.)

      * Future pathologists: Use electron microscope to find tubulovesicular mitochondria, which are characteristic of adrenal cortex. Criteria for malignancy have been developed; since this cancer is not particularly treatable, their usefulness is limited.

Adrenal cortical carcinoma
Pittsburgh Pathology Cases

Adrenal cortical carcinoma
Pittsburgh Pathology Cases

Adrenal cortical carcinoma

WebPath Photo

Adrenal cortical carcinoma

WebPath Photo

Adrenal cortical carcinoma

WebPath Photo

{24087}      adrenal cortical carcinoma, gross
{40196}      adrenal cortical carcinoma
{24090}      adrenal cortical carcinoma, histology

    NOTE: Cancer in the adrenals is usually metastatic carcinoma. Half of all lung cancers eventually metastasize to the adrenals. Adrenal insufficiency sometimes results when replacement is massive, but is usually missed clinically.

Metastatic cancer in the adrenals

WebPath Photo

Cancer metastatic to the adrenal
AFIP
Wikimedia Commons

THE ADRENAL MEDULLA: "An organ not essential to life".

    Around 10% of the normal adrenal by weight. The source of "adrenalin" (epinephrine, also norepinephrine). At autopsy it is gray, unless it has autolyzed.

    "Adrenal medullary hyperplasia" (i.e., the medulla is too big; one way to tell is that it extends into the tail, where it's not supposed to go) is a marker for MEN II and a few rarities. It can be diffuse or nodular, and it may be best to call any nodule bigger than 1 cm a pheochromocytoma.

    The only bona-fide diseases are two tumors that may arise here or at the other chromaffin tissue masses -- pheochromocytoma (well-differentiated, adults) and neuroblastoma (poorly-differentiated, children).

    * The story of the old adrenal-to-brain transplant for parkinsonism: Mayo Clin. Proc. 65: 305, 1990.

PHEOCHROMOCYTOMA ("paraganglioma", "pheo", formerly "ten percent tumor"; big NIH consensus review Ann. Int. Med. 134: 315, 2001; big review for pathologists Arch. Path. Lab. Med. 132: 1272, 2008).

    This tumor is named for its colorful reaction in fixatives containing chromic acid salts.

      Pheochromocytomas secrete norepinephrine (most common) and/or epinephrine (usually less, * and often other things, including dopamine, serotonin, ACTH, somatostatin, neuropeptide Y, and/or VIP; Cancer Res. 49: 7010, 1990).

      Pathologists confirm that a likely-looking tumor is a pheochromocytoma by staining it up for chromogranin and/or synaptophysin.

      The infamous paroxysms of extreme hypertension, accompanied by sweating, headache, and other autonomic disturbances, probably result from physical compression and/or ischemia of the "pheo".

      Even a tiny (1 gm) benign pheochromocytoma can make a person very sick and will eventually cause death.

      Today, "pheochromocytoma" is defined to arise in the adrenal medulla. Similar tumors (less common) arising elsewhere are called "extra-adrenal paragangliomas." These sites include the organs of Zuckerkandl ("para-aortic bodies", i.e., the little nubbins of chromaffin tissue at the origin of the inferior mesenteric artery and/or aortic bifurcation -- prominent and surely important in the unborn child, but regressed by birth), paravertebral sympathetic chain, urinary bladder (patients get terrible headaches whenever they urinate), or "paraganglia" such as the carotid body.

      The old business about "ten percent of pheo cases involve both adrenals, 10% are familial, and 10% metastasize" is history. Today, everything's about the new genetics.

        Up to 30% of affected people seem to have a germline mutation -- see Arch. Path. Lab. Med. 132: 1272, 2008). Syndromes include:

        • MEN IIa or IIb (RET) -- these are the patients who are likely also to have hyperplasia of the adrenal medulla
        • von Recklinghausen's neurofibromatosis (NF-I)
        • von Hippel-Lindau (JAMA 275: 839, 1996, pheo-only allele J. Clin. Endocrin. Metab. 81: 147, 1996; there are now four subtypes conferring various risks for various tumors depending on mutation)
        • succinic dehydrogenase mutation (really; J. Clin. End. Metab. 86: 2890, 2001; Lancet 357: 1181, 2001; update on the clinical presentation and the tendency of these tumors to arise outside the adrenals and to be aggressive: J. Clin. Endo. Metab. 91: 790, 2006). There are three loci (SDHB, SDHC, SDHD; * faulty SDHC is imprinted and can only be inherited from Dad)
          Sporadic pheos usually do NOT have any of these genes mutated. Pheo patients need to be screened for germline mutations, and if positive, their family members need to be screened as well (J. Clin. Endo. Metab. 94: 1701, 2009).

        * "Composite pheo" contains some neuroblastoma, ganglioneuroblastoma, or nerve-sheath tumor; think of MEN II or neurofiromatosis. If there's no neroblastoma, the presence of other elements is probably not a bad prognostic indicator. Update Am. J. Clin. Path. 132: 69, 2009.

      You will often be reminded of the MEA ("MEN", "multiple endocrine adenoma/neoplasia syndromes") -- common autosomal dominant conditions that predispose patients to certain endocrine tumors. Pre-natal diagnosis is available for these tumor-gene syndromes. Learn them now:

        MEN I: PPP (Wermer's syndrome), protein menin * on 11q13

          Parathyroid adenoma(s) (1 or, often, more glands) / "chief cell hyperplasia" (i.e., all four glands): NEJM 321: 213 1989).

          Pituitary adenoma (anterior)

          Pancreatic islet cell adenoma (gastrinoma)

            * Bronchial and thymic carcinoids too... the latter mostly in middle-aged men who smoke a lot. Medicine 76: 21, 1997.

            * The pituitary-and-parathyroid-only variant usually is from a different locus that remains to be discovered: J. Clin. Endo. Metab. 92: 1948, 2007.

        MEN IIa: PAC (Sipple's syndrome); the RET gene (Nature 367: 315, 375, 377 & 378, 1994; NEJM 335: 943, 1996; J. Clin. End. Metab. 81: 2711, 1996; screening for the gene J. Clin. Endo. Met. 78: 1261, 1994 and Mayo Clin. Proc. 72 430, 1997; new alleles keep appearing J. Clin. Endo. Metab. 89: 4142, 2004; surveillance J. Clin. End. Metab. 82: 897, 1997).

          Parathyroid adenoma(s) (1 or, often, more glands) / "chief cell hyperplasia"

          Adrenal medullary tumor (pheochromocytoma) or hyperplasia

          Calcitonin-producing hyperplasia-carcinoma of thyroid

        MEN IIb (MEN III):

          Similar to MEN IIa; the patients have Marfanoid body habitus and mucosal (ganglio)neuromas (bumps on the edges of their tongues and elsewhere), and probably will not have parathyroid problems. Same locus, different allele (Nature 1994, see above.)

        Patients with MEN II may first have adrenal medullary hyperplasia, which can be nodular. Nodules over 1 cm are best considered pheos.

    Grossly, pheos are very bloody (because they are very vascular), and often show fibrosis, calcification, cystic change, or even * fatty change (?!)

    Microscopically, pheos resemble adrenal medulla.

      Special stains are available that show norepinephrine and/or epinephrine in granules (* future pathologists: aqueous fixation washes them out.) Contrary to what anybody else may have told you, the granule morphology means nothing: Br. J. Surg. 85: 1681, 1998. Nowadays, a tumor that stains for phenylethanolamine-N-methyltransferase (PNMT) has the "adrenergic phenotype", one that doesn't has the "noradrenergic phenotype".

      Of course, that's history now. Pheos light up with chromogranin A and tyrosine hydroxylase. Extra-adrenal paragangliomas light up with chromogranin A but often not with tyrosine hydroxylase.

      For pheos, the traditional teaching has long been that there are no histologic criteria for malignancy, not even vascular invasion. The honest pathologist cannot predict the tumor's behavior.

        * The most recent effort (Surgery 143: 759, 2008), from Memorial Sloan-Kettering, provides a scoring system based on twelve histologic parameters, including a bunch of special stains (notably Ki-67 / MIB-1). Tumors with scores of four or less all proved to act benign; those with higher scores were unpredictable.

      To prove malignancy you must find pheo in a location where it could not have arisen. Five-year survival rate with malignant pheo is around 50%.

      * "Pheo balls" are hyaline spheres that can be very big. You can see them in most normal medullas if you look hard enough. They must be thanatosomes. Fun to know: They are acid-fast and autofluorescent!

      More fun: A pheo or neuroblastoma, as a frozen section, exposed to formalin, fluoresces yellow-green from the catecholamines getting altered.

    Regardless of location and appearance, the patients will report anxiety, headache, palpitations, "panic attacks", sweating, dizziness, etc. (Again, you may suspect the basic problem is emotional. "Pheo is a great imitator.")

      "Textbook" pheochromocytoma patients have paroxysms of severe hypertension. Actually, the majority show sustained high blood pressure.

    Pheochromocytoma is present in fewer than 1% of people with high blood pressure, but it's a diagnosis you don't want to miss.

      Pheos are still often missed clinically (Am. J. Surg. 179: 212, 2000) and are all-too-familiar surprises at autopsy (Lancet 335: 1189, 1990). The patients typically had been told they had "benign essential hypertension" and "emotional problems".

      In addition to causing bad high blood pressure and all that goes with it, high levels of circulating catecholamines can directly (and likely permanently, as with cocaine) damage the myocardium can cause coronary spasm, and can play havoc with smooth muscle (renal arteries, bowel, brain, etc. -- angiographers may report "vasculitis".)

      Screening tests for pheos detect increased amounts of catecholamines or their metabolites in blood or urine.

        The classic screen for pheos (24 hour urinary vanillylmandelic acid -- VMA) is being superseded by more sensitive and specific tests.

        Today's "most sensitive screen" is the plasma free metanephrine assay (Ann. Int. Med. 134: 315, 2001; Arch. Int. Med. 160: 2521, 2000; JAMA 287: 1427, 2002).

        There's a radioisotope scanner/treatment for pheo and neuroblastoma -- I-131 labeled metaiodobenzylguanidine (MIBG); it's not very sensitive for diagnosis (J. Clin. Endo. Metab. 86: 685, 2001).

          Using 131-I-MIBG for metastatic malignant pheochromocytoma treatment, with very good results: Cancer 98: 239, 2003; J. Clin. Endo. Metab. 90: 5888, 2005.

        * Finding the hidden pheo using novel techniques, including 6-[18F]-fluorodopamine: J. Clin. Endo. Metab. 86: 3641, 2001.

        * The Mayo crew examines how much it would cost to screen every hypertensive patient for pheo using each of three methods, and simply states that spending $50,000 or $100,000 per patient found isn't worth it (J. Clin. Endo. Metab. 89: 2859, 2004); I am not sure I agree, and certainly you need to work up the young ones, the ones with headaches, and the ones with "nerves".

    Treatment is surgical, with very careful management of fluid status and blood pressure before and after surgery (J. Urol. 161: 764, 1999). The anesthesiologist, of course, has an extra challenge (Anesth. Analg. 91: 1118, 2000). And surgeons must be careful manipulating the tumor! Adrenal sparing surgery, i.e., let's leave a bit of cortex behind: Br. J. Surg. 86: 94, 1999. Today, it's likely that the tumor will be removed successfully via the laparoscope (Urol. Clin. N.A. 28: 97, 2001).

    * Injecting epinephrine to fake a pheo: JAMA 266: 1553, 1991 (weird!).

{20316}      pheochromocytoma in adrenal, gross
{25417}      pheochromocytoma, gross
{49444}      pheochromocytoma, gross
{09226}      pheochromocytoma, gross
{09227}      pheochromocytoma, showing positive brown staining with chromic acid ("chromaffin")
{08874}      pheochromocytoma, histology
{08873}      pheochromocytoma, histology
{25418}      pheochromocytoma, histology
{09228}      pheochromocytoma, histology
{09229}      pheochromocytoma, histology, positive chromaffin reaction
{09080}      pheochromocytoma, electron micrograph showing granules
{09081}      pheochromocytoma, electron micrograph showing granules
{08056}      pheochromocytoma cardiotoxicity
{08053}      pheochromocytoma cardiotoxicity; note contraction bands

Pheochromocytoma

WebPath Photo

Pheochromocytoma
Chromaffin reaction
WebPath Photo

Pheochromocytoma

WebPath Photo

Pheochromocytoma

WebPath Photo

Pheochromocytoma
Electron micrograph
WebPath Photo

Paragangliomas
Pittsburgh Pathology Cases

NEUROBLASTOMA (Ped. Clin. N.A> 55: 97, 2008)

    Either Wilms tumor or neuroblastoma is the most comon extracranial solid cancer of children. It is derived from primitive nerve elements (* and the cells will always grow neurites, at least in tissue culture). Discovered by Virchow.

      A majority of neuroblastomas arise in or near the adrenals.

      They seem to strike at random. * Three risk loci, all at 6p22, have been spotted (NEJM 358: 2585, 2008).

    Grossly, neuroblastomas are soft, white tumors.

      Portions often undergo dystrophic calcification (which helps the radiologist make the diagnosis.)

      The tumor eventually metastasizes widely. "Blueberry muffin baby" is a repulsive, classic description for a neuroblastoma patient with multiple skin metastases.

    Histologically, neuroblastoma is a tumor of "small blue cells" (i.e., cancers with small, fairly-uniform cells with scanty cytoplasm). Often (but not always) the cells are arranged in "rosettes" (recalling neural tubes) around a tangle of neurites (* "Homer Wright rosettes", pretty-much diagnostic). EM shows neurosecretory granules and often neurites too. (* True "Flexner" rosettes surround a hole. Think of ependymomas or retinoblastomas.)

      * Future pathologists: Immunohistochemistry helps differentiate this from other "tumors of small blue cells" (the LEMON family), and will also help you recognize their nondescript cells in bone marrow. The better-differentiated neuroblastomas are likely to stain positive for neuron specific enolase, S-100, and/or synaptophysin, but the more primitive ones will be negative for everything. In tissue culture, neuroblastoma cells sprout neurites almost at once.

      Grading of the tumor is based on mitotic figure counts, with karyorrhexis being taken into account nowadays also: Cancer 77: 1582, 1996 updates the older Shimada system. The most recent update is the "International Neuroblastoma Pathology Committee" system (Cancer 86: 364, 1999; Cancer 92: 2451 & 2699, 2002; Cancer 94: 1574, 2002). "MKI" is the "mitosis-karyorrhexis index", i.e., what percent of cells exhibit these; more than 4% is bad (2% if the child is over 1.5 years).

    Most neuroblastomas produce catecholamines, resulting in elevated urinary metabolites. (* They also produce certain characteristic protein markers, etc., etc.)

      The classic test involves checking urine for homovanillic acid (HVA) and vanillylmandelic acid (VMA). Japan screens all babies at six months of age (Lancet 2: 152, 1988); skeptical Brits suggest that they find only regressing tumors (Lancet 337: 344, 1991). The Germans have screened their babies at one year and find it lot of cases, but I couldn't tell whether they're saving lives (J. Clin. Onc. 17: 1200, 1999 -- anybody want to do a lab presentation on this?). Now the Japanese are doubting whether they've saved any lives, either (Canc. Caus. Contr. 9: 631, 1998; "we haven't" J. Ped. Surg. 37: 949, 2002). Neuroblastoma screening has not caught on in the US in the "managed care era"; both big studies indicated it's a bad idea NEJM 346: 1041 & 1047, 2002.

      There are also a variety of curious (probably autoimmune) paraneoplastic syndromes that result from neuroblastomas, including neurodegenerative disorders similar to those in oat-cell carcinoma.

    Prognosis in neuroblastoma:

    • better for younger patients

    • paradoxically, it's also BETTER when the tumor is aneuploid (a robust finding: Cancer 91: 435, 2001)

    • Calcification is a good sign

    • n-myc (now MYCN) amplification is a bad sign;

    • the more S100+ cells the better

    • mitotic counts (MKI's) <100/5000 cells good, >200/500 cells bad

    • newer work suggests that short telomeres are the best of all prognostic signs (Cancer 107: 1391, 2006)

    And of course, it's good if the cells are differentiating...

    • undifferentiated: no cells show maturation (i.e., turning into neurons)

    • poorly differentiated: <5% of cells show maturation

    • differentiating: 5+% of cells show maturation

    In a baby, the tumor is likely to regress/differentiate/mature (to a stroma-rich GANGLIONEUROBLASTOMA or a thoroughly benign GANGLIONEUROMA; Br. J. Surg. 83: 263, 1996). In 2% of autopsies on infants dying of unrelated causes, there is a neuroblastoma-like "incidentaloma". Obviously most of these cure themselves. We wish we knew exactly why/how this happens.

      * The process begins with the appearance of S100-positive Schwann cells, which are from outside the tumor. If the tumor is to self-cure, it must be near-triploid and have intact chromosome 1 (NEJM 334: 1505 & 1537, 1996).

{24716}      neuroblastoma, histology, good rosettes
{25420}      neuroblastoma, gross
{25422}      neuroblastoma, histology
{39049}      neuroblastoma, gross; probably an incidental finding in a newborn
{09009}      neuroblastoma, histology
{09232}      neuroblastoma, histology
{20046}      neuroblastoma, histology
{20047}      neuroblastoma, histology
{09011}      neuroblastoma, histology, good rosettes
{08963}      neuroblastoma histology (sorry, no good rosettes)
{25424}      ganglioneuroblastoma, histology
{25426}      ganglioneuroblastoma, histology
{24608}      ganglioneuroma, gross

Neuroblastoma rosette
AFIP
Wikimedia Commons

Child with neuroblastoma
AFIP
Wikimedia Commons

Neuroblastoma

WebPath Photo

Neuroblastoma

WebPath Photo

Neuroblastoma
WebPath Photo

Neuroblastoma
WebPath Photo

    In toddlers, spontaneous remission is less likely, but even metastatic disease is often cured by chemotherapy.

    In older kids and adults, neuroblastomas grow slower but seldom self-cure or respond well to therapy (Cancer 79: 2028, 1997).

      * Stay tuned for monoclonal antibodies as a mainstay in the treatment of difficult neuroblastoma patients: Heme-Onc. Clin. N.A. 15: 853, 2001.

    Retinoblastomas (cones of the eye), medulloblastomas (cerebellum), pinealoblastomas (pineal), and adult neuroblastomas (lots of places -- many of these are probably Ewing variants) are related pediatric tumors that look like neuroblastomas microscopically.

      * The tendency today is to call these "primitive neuroectodermal tumors", despite obvious differences in their basic biology.

      * Neuroblastoma of the olfactory epithelium is a special entity.

INTRODUCTION TO ADRENAL TESTING

    The aphorism -- "A physician is only as good as his/her index of suspicion" -- is especially applicable to endocrine disease. As an alert clinician, you will often suspect adrenal gland problems and will want to order sensitive tests.

    Some classic cases:

    • the thin, tired patient who has no appetite: ADDISON'S DISEASE?
      • Order a rapid ACTH ("cosyntropin", "synacthen") stimulation test

          Give an injection of 250 mg of synthetic ACTH, intramuscularly or intravenously.

          After 30-60 minutes, the serum cortisol should spike to at least 500 nanomoles/Liter = 18 micrograms/dL.

          If it doesn't, you have adrenal insufficiency, either primary (the glands are diseased) or secondary (the glands atrophied from lack of ACTH stimulation).

          In the past, we used to give an ACTH stimulation test each day for a week; patients with secondary adrenal insufficiency would grow their adrenals back from the test (and probably want to come back for more!)

          Injected ACTH clears in a few minutes. Nowadays, just take your 30-minute blood sample and check serum ACTH (it'll probably still be high in primary adrenal disease, low-ish in pituitary insufficiency). Also check serum aldosterone in the same sample; the ability of the adrenals to produce aldostone isn't lost as much as the ability to produce cortisol when the problem is in the pituitary gland. A lack of a normal spike after ACTH administration confirms primary adrenal insufficiency.

          A "spot serum cortisol" is worthless (the stress of venipuncture can cause a false negative.) A "24 hour urine cortisol" is worthless (it can be zero in health.) A "spot serum ACTH" is worthless. It's secreted in pulses.

    • the patient who is gaining weight and who is depressed, has high blood pressure, has hyperglycemia, or has one of many other problems: CUSHING'S SYNDROME?
      • Order serum cortisol determinations at 8 AM and 8 PM (circadian rhythm is always lost in Cushingism), plus a low-dose dexamethasone suppression test, OR just order one (or maybe two or three) 24 hr urinary free cortisol assays.

    • the patient with high blood pressure (with or even without a low serum potassium): ALDOSTERONISM?
      • Screen with a serum aldosterone/renin ratio. If high, measure urine aldosterone on a high-salt diet AND/OR see whether you can suppress the aldosterone using fludrocortisone AND/OR check to see if plasma aldosterone fails to increase on standing up AND/OR consider performing a saline infusion aldosterone-suppression test AND/OR consider a CT scan. Nobody really knows what's best. Current thinking: J. Clin. Endo. Metab. 91: 2618, 2006.

    • the lady who's starting to grow a mustache: LATE-ONSET CONGENITAL ADRENAL HYPERPLASIA?

        Administer ACTH and measure blood 17-OH-progesterone.

    • the nervous patient with high blood pressure and headaches: PHEOCHROMOCYTOMA?
      • Check serum/urine catecholamines and/or metabolites, ask your lab.

    Of course, only some of these patients are endocrine cases. As a rule, meaningful hormone assays are performed under conditions of attempted stimulation (if you suspect deficiency) or attempted suppression (if you suspect over-production). If your screening tests are positive, or if you have any doubts, get consultation. (One problem is that reliable, cheap plasma ACTH assays are still not routinely available.)

    If you diagnose endocrine disease that is not present, the patient gets lifelong medication, unnecessary surgery, or unnecessary radiation. If you fail to diagnose a disease that is present, the patient is likely to die of a disease that might have had an excellent prognosis. (Suicide is common among patients with untreated Cushing's syndrome.) If you make the correct diagnosis, the treatment of endocrine disease is very satisfying to physician and patient alike -- because it works.

PARATHYROID GLANDS: ANATOMY AND PHYSIOLOGY

Parathyroid Exhibit
Virtual Pathology Museum
University of Connecticut

Parathyroids
"Pathology Outlines"
Nat Pernick MD

    The parathyroids arise from the third and fourth branchial clefts. They are each 3-4 mm across and weigh maybe 35 mg each (there is no consensus about "ideal total weight").

    * They were first discovered by Richard Owen in 1850 in a rhinoceros in the London zoo. Virchow (who else?) discovered them in humans.

    Future surgeons: The key to telling a parathyroid gland / tumor at surgery is that (unlike fat, thyroid nubbins, or lymph nodes), a droplet of blood will ooze up when the gland is pricked by your scalpel blade. Why?

Normal parathyroid

WebPath Photo

Parathyroid Histology
Ed's Histology Notes

    Textbooks show four. Most people have 3 or 4 parathyroids, less often 5 or even 6.

      Unusual locations (especially for the lower pair) are common and explainable embryologically.

      "Ectopic" parathyroid glands may be found in the carotid sheaths, behind the esophagus, in the anterior mediastinum, in the pericardial sack, thyroid gland, etc. The new sestamibi scan has made finding these much easier.

      Cysts are uncommon but do occur (J. Otol. 18: 311, 1990).

    Cell types in the normal glands:

      Chief cells: typical hormone-secreting endocrine cells

      Oxyphils ("oncocytes"): large, pink-staining cells that appear after puberty and occur in clusters. (By EM, these are seen to be packed with mitochondria, like Hürthle cells. They do not contain secretory granules, and the mitochondria are probably not metabolically active. Oxyphils are more numerous in older people.)

      "Water-clear cells" ("wasserhelle" cells): seen in some parathyroids. (They are full of glycogen, and their functional status is uncertain.)

      Fat cells: after puberty. "Fatty ingrowth", if you like.

    Parathyroid hormone is the major regulator of calcium homeostasis in humans.

      Its production-secretion is regulated by serum calcium levels.

        Today's "i-PTH" (intact parathyroid hormone) assay is a long-time pathologist's dream, and requires a two-antibody technique. It's replacing the classic N-terminal and C-terminal assays.

        The N-terminal assay measures the active hormone, though the form measured by the C-terminal portion stays around longer. (Pitfall: the C-terminal portion is filtered through the kidneys, and is increased when the kidneys are underfunctioning even if parathyroid function is normal.)

        Historically, I've suggested measuring both. With high PTH, high calcium, and low phosphorus, you have your diagnosis. Today's i-PTH (intact PTH) might be more expensive but is available stat for use during surgery. Other labs aren't so useful. (Did you know that urinary cyclic AMP is a good estimate of parathyroid hormone levels?)

      Effects:

        Kidney: Promotes conversion of 25-OH-D3 to the very active 1,25-OH-D3 that increases calcium absorption from the gut.

          Promotes resorption of calcium from the glomerular filtrate, and promotes loss of phosphate.

            This effect is mediated by activation of adenylate cyclase. Serum parathyroid levels are accurately reflected by measuring urinary c-AMP concentrations.

        Bone: Promotes resorption of calcium by osteoclasts (via activation of adenylate cyclase.)

          Increased levels of parathyroid hormone causes proliferation of osteoclasts. (Finding of an osteoclast in a section of non-pagetic, non-injured bone from an adult usually means hyperparathyroidism.)

        Gut: Promotes calcium absorption (indirect effect, via vitamin D activation).

HYPERPARATHYROIDISM ("stone and bone disease"; review Mayo Clin. Proc. 77: 87, 2002)

    PRIMARY HYPERPARATHYROIDISM: Due to disease of the parathyroid glands. Pathologists see Arch. Path. Lab. Med. 132: 1251, 2008).

        80-85%... parathyroid "adenoma" ("single gland disease")
        10-15%... parathyroid "hyperplasia" ("multiple gland disease", usually all four glands)
        maybe 1%... parathyroid carcinoma (I think this traditional number is high)

        <1%... iatrogenic seeding causing lots of little glands: Hum. Path. 21: 234, 1990, (* by my teacher, Dr. David Roxe); Surgery 116: 111, 1994.

        Some people may also use this term to include hypercalcemia caused by production of parathyroid-hormone-like activity (PTH-rP) by cancers, notably squamous lung cancer), or very rarely real PTH. Today the term "pseudohyperparathyroidism" is preferred.

      Primary hyperthyroidism is a common clinical problem. About 1 person in 1000 will need parathyroid surgery during his or her lifetime. When serum calcium was added to the chemical profiler in 1974, a huge number of patients were found and much good was done by removing their tumors.

        A person with MEN I has about an 85% lifetime chance of getting primary hyperparathyroidism; a person with MEN II has about a 20% chance. These are usually hyperplasias.

      Calcium rises because of enhanced GI absorption and renal reabsorption. There is also a tiny contribution from increased osteoclastic activity (Am. J. Med. Sci. 320: 334, 2000).

      Symptoms and signs:

        Elevated serum calcium on routine screening (probably the commonest presentation today)

        Mental changes (depression, psychosis; Am. J. Med. 101: 111, 1996)

        Kidney stones (the commonest presentation in the past)

        Nephrocalcinosis (metastatic calcification in the tubular basement membranes with eventual damage to the tubules)

        Bone changes (first osteomalacia, then widespread involvement of the skeleton by increased osteoclastic activity especially in the centers of trabeculae; finally cystic lesions variously known as "osteitis fibrosa cystica", "von Recklinghausen's disease of bone", or "brown tumors." All this heals after the hyperparathyroidism is fixed.)

        Most extreme: Calciphylaxis (metastatic calcification of the skin, with horrible ulcers and breakdown): South. Med. J. 102: 318, 2009.

Brown Tumor of Hyperparathyroidism
Pittsburg Illustrated Case

Brown tumor
Pittsburgh Pathology Cases

Brown tumor
WebPath Tutorial

Brown tumor
WebPath Tutorial

        Just not feeling right. Hypercalcemia makes you fatigued before anything else. People who eventually turn out to have primary hyperparathyroidism are much more likely to have been missing a lot of work "for being sick" for several years prior to diagnosis (BMJ 317: 848, 1998.) After surgery, "asymptomatic" people with parathyroid adenomas feel a lot better (Surgery 128: 1013, 2000).

        Resorption of the tufts of the phalanges on x-ray

        * "Band keratopathy" of Bowman's membrane in the cornea

        * Loss of lamina dura on dental x-rays

        Gastric ulcers (5%; hypercalcemia from any cause enhances gastrin secretion)

        Hypertension (50%, cured by parathyroid surgery only if the kidney is undamaged)

        Pancreatitis (occasionally)

        Pseudogout (occasionally)

        * NMJ problems (denervation-atrophy picture on muscle biopsy)

        * Skin ulcers (following metastatic calcification of vessels: Arch. Path. Lab. Med. 114: 482, 1990).

      Labs:

        high serum calcium

        low serum phosphate

        high 24-hour urine calcium excretion (i.e., you absorb a lot more through your gut)

        high urinary cAMP (old-fashioned test)

        high serum parathyroid hormone (PTH) for your screening

    PARATHYROID ADENOMA

      The commonest cause of primary hyperparathyroidism.

        * In the mid-1980's, there was a fad notion that these all represented "nodular hyperplasia". Newer genetic studies have shown these tumors truly are monoclonal. Well usually. And often the hyperplasias are clonal. It's blurry.

      These tumors are most common in older women, but may occur in anyone. They average around a gram but are sometimes bigger.

        The basic biology very often involves translocations that deregulate the oncogene PRAD-1 (bcl-1, cyclin D1, a cell-cycle regulator; Nature 350: 512, 1991, much more since).

        * When I first begin preparing these notes in the 1980's, I mentioned that I'd seen several at autopsy that were probably non-functional. In the scanning era, surgeons are now making the same discovery (Surgery 138: 1111, 2005).

      The surgeon finds three normal glands and an adenoma that is easily removed (10% are in an "ectopic location.)

      In the late 1990's, parathyroid surgery was revolutionized by the introduction of the Tc99 sestamibi scan to locate the lesion(s) preoperatively, and intraoperative radioguidance (Arch. Surg. 135: 481 & 550 & 844 & 1461, 2000; Ann. Surg. 23: 31 & 331 732, 2000; J. Am. Coll. Surg. 190: 540, 2000; Surg. Clin. N.A. 80: 1399, 2000; Surgery 129: 720, 2001; Arch. Surg. 137: 659, 2002).

        The sestamibi scan lights up mitochondria, so it's a good way to show up parathyroids. The surgeon can draw a iPTH (intact PTH) level before and soon after (half life is five minutes) excising the suspected lesion; if it drops 50% or more, supposedly your operation was a success. (See Arch. Surg. 136: 536, 2001; Surgery 128: 1029, 2000.) Nowadays, it seems quite clear that iPTH it can indeed be used as a "chemical frozen section", and satellite labs are appearing in operating suites. Pathologists will be doing a lot fewer frozen sections / imprint cytologies on the cases (Arch. Path. Lab. Med. 127: 1424, 2003; shucks, I used to love doing these). It's usually an outpatient procedure done under a local anesthetic.

          Occasional overfunctioning glands do fail to "light up", especially if they are very small or lack abundant mitochondria (Arch. Oto. 131: 493, 2005).

          * Imprint cytology of the parathyroid and other neck structures at surgery: Arch. Path. Lab. Med. 127: 64, 2003; Am. J. Clin. Path. 118: 895, 2002.

      The adenoma often has a rim of compressed normal gland at the edge. Most adenomas contain few if any adipocytes, and most of the cells do not have intracytoplasmic fat.

        An adenoma can be composed of any of the three kinds cells (chiefs, oxyphils, waterclears).

          * All take up Tc99-sestamibi well; oxyphil-rich adenomas are the best (Arch. Otol. 132: 779, 2006).

      As you would expect, parathyroid adenomas (even in people with no family history) often lack 11q13 (the MEN-I locus).

      * Every once in a while, there is so much fat in a parathyroid adenoma that it looks like a lipoma, i.e., the infamous "lipoadenoma".

{10827}      parathyroid adenoma, histology

Parathyroid adenoma
Note rim of normal tissue
WebPath Photo

Parathyroid adenoma
Oxyphilic type
WebPath Photo

    PARATHYROID CARCINOMA (Cancer 100: 900, 2004; Surgery 142: 936, 2007)

      A rare cause of primary hyperparathyroidism.

        By definition, this cancer arises in a parathyroid gland and produces parathyroid hormone.

          * Future pathologists may enjoy reading about the trabecular pattern that is supposed to be distinctive. Desmoplasia also is a marker of parathyroid cancer. You are less likely to see obvious invasion or numerous or weird mitotic figures. As in adrenal adeonomas, thyroid adenomas, and pheochromocytomas, hyperchromatic nuclei ("endocrine atypia") don't mean cancer.

          A familial syndrome of parathyroid adenomas and carcinomas involves mutant HRPT2 (parafibromin: NEJM 349: 1722, 2003); this gene is not mutated in parathyroid adenomas, either familial or sporadic (J. Clin. Endo. Metab. 90: 5015, 2005).

            * Loss of parafibromin nuclear reactivity as a marker for malignancy: Clin. Canc. Res. 10: 6629, 2004. Not surprisingly, and in contrast to other genetic syndromes, it also disappears in involved parathyroids in familial isolated hyperparathyroidism (HRPT2 / parafibromin locus, cited above).

            * Loss of Rb, reportd in the 1990's, was a disappointment; loss of heterozygosity for this and other anti-oncogenes is noted in some tumors showing bizarre mitoses, invasion, or metastases (Surgery 144: 949, 2008); we await studies with adenomas as controls.

            * Today, the "other" marker stain that indicates malignancy in a parathyroid tumor is PGP9.5 (J. Clin. Endo. Metab. 94: 434, 2009).

      These cancers are somewhat aggressive. About a third are cured with simple excision, another third recur and require re-operation for cure, and only a third eventually metastasize and ultimately cause death, usually from refractory hypercalcemia. Sestamibi scanning has greatly improved the management of these tumors (Clin. Nuc. Med. 32: 358, 2007).

      * Please leave the distinction among "parathyroid carcinoma", "atypical parathyroid adenoma", and "parathyromatosis" to us pathologists. Thanks. Cancer 110: 255, 2007.

Parathyroid carcinoma

WebPath Photo

Parathyroid carcinoma

WebPath Photo

    PARATHYROID HYPERPLASIA

      The second most important cause of primary hyperparathyroidism. All four glands are big, for no obvious reason. Even though this is "a different disease from adenomas", the masses are often clonal, and (in the case of chief-cell hyperplasia) the same genes put you at risk.

        * Watch for the name of "primary parathyroid hyperplasia" to change to "multiple parathyroid gland neoplasia." The lesion in kidney disease is a true hyperplasia.

      This may occur in anyone, but is suspicious for one of the multiple endocrine neoplasia (multiple endocrine adenomatosis) syndromes. See below.

      Hyperplastic glands usually lack the usual fat cells.

    CHIEF CELL HYPERPLASIA is the common kind. It raises the possibility of MEN I or MEN II. Older techniques to tentatively distinguish a hyperplastic gland from an adenoma on morphology have fallen into disuse.

    WATER-CLEAR HYPERPLASIA is a different disease with the same symptoms. All four glands are quite big, probably because there is much non-functioning cytoplasm in the clear cells. This time, there is no intracellular lipid but plenty of glycogen.

      Clear-cell lesions do not show well with sestamibi. The MEN syndromes do NOT place you at risk for it. Waterclear hyperplasia is becoming uncommon for some reason. And you must have a blood group "O" allele to get it (Hum. Genet. 94: 195, 1994)!!! Gee whiz. Waterclear adenomas are almost unknown (Arch. Path. Lab. Med. 125: 256, 2002).

{27260}      parathyroid hyperplasia (arrow sign helps)
{09271}      primary parathyroid hyperplasia, histology

Parathyroid hyperplasia

WebPath Photo

Parathyroid hyperplasia
You cannot tell this from adenoma by itself
WebPath Photo

Parathyroid hyperplasia
Note cell uniformity. Uremia.
KCUMB Team

    In parathyroid hyperplasia, the bulk of the parathyroid tissue must be removed, leaving a small amount behind. (Sometimes a small amount of parathyroid tissue gets transplanted to the forearm, for future whittling.)

      This is now routine. You can use the sestamibi scan to see if the graft is over-functioning: South. Med. U. 93: 215, 2000.

      NOTE: The honest pathologist CANNOT distinguish a hyperplastic gland from an adenoma! The surgeon MUST send samples of two glands. (Why? Confirmed yet again.... Surgery 142: 930, 2007) The pathologist will report "hypercellular parathyroid tissue". We can tell the second (normal) gland easily using a touch-prep cytology.

    SECONDARY HYPERPARATHYROIDISM: Parathyroid hyperplasia due to hypocalcemia (or hyperphosphatemia, or hPTH resistance, or vitamin D deficiency, or vitamin D resistance) from some other cause, usually renal failure (less often malabsorption or malnutrition).

      In people who are vitamin D deficient, the extra parathyroid hormone keeps calcium levels normal (J. Clin. Endo. Metab. 85: 4125, 2000; Am. J. Med. Sci. 319: 380, 2000; remember there's plenty of this in the US); serum parathormone levels are part of the screen especially by epidemiologists.

      Less common causes are intestinal malabsorption, calcitonin-producing tumors (i.e., medullary carcinoma of the thyroid) and rickets (low serum phosphate, in contrast to renal failure, in which serum phosphate levels are high.)

      Serum calcium is low-normal.

      Bone disease (as in primary hyperparathyroidism, but now called "renal osteo-dystrophy") is a big problem. Some patients may need partial parathyroidectomy to control it.

      Today's patient with secondary hyperparathyroidism of renal origin will probably be controlled adequately with oral, or perhaps intravenous, calcitriol (Am. J. Med. Sci. 320: 100 & 107, 2000).

    TERTIARY HYPERPARATHYROIDISM: Hypercalcemia develops in a setting of secondary hyperparathyroidism.

      One or more glands has "become autonomous" and overproduces parathyroid hormone. Probably this means it has lost the MEN-I anti-oncogene on chromosome 11 (J. Clin. End. Met. 76: 139, 1993). Thankfully rare.

    * NOTE: Genetic typing of parathyroid masses has helped us recognize that the above scheme, while a bit simplistic, is fundamentally accurate. If one gland is involved, it's an adenoma and will show one of two different genetic profiles. If two, three, or four glands are involved, it's "multiple gland parathyroid neoplasia", with different genetic signatures for each. See Am. J. Path. 165: 565, 2004.

    OTHER HYPERPARATHYROID SYNDROMES:

      FAMILIAL HYPOCALCIURIC HYPERCALCEMIA, also called "familial benign hypercalcemia", a mild, autosomal dominant disorder.

        In the 1970's, many of these folks were operated in search of parathyroid disease... sorry!

        The mutation is in CaSR, the calcium sensing receptor (Clin. End. 50: 537, 1999; Am. J. Hum. Genet. 64: 189, 1999), which tells the nucleus what the plasma calcium level is. Parathyroid hormone is overproduced as a result.

          * Fun to know: CaSR is autoantigen in the parathyroid disease in autoimmune parathyroid disease: J. Clin. Endo. Metab. 92: 2107, 2007.

        * Two doses gives neonatal severe primary hypercalcemia requiring total parathyroidectomy.

        * Other mutations give a familial hypocalcemia (J. Clin. Endocrin. Metab. 84: 363, 1999), i.e., in these "activating" mutations, the receptor is stuck in the "on"-position. An autoantibody that causes the same problem: NEJM 351: 362, 2004.

        Order a calcium-creatinine clearance ratio, which will be very low (less than .01) in these patients.

      JANSEN'S METAPHYSEAL CHONDRODYSPLASIA, an autosomal dominant syndrome caused by an overactive PTH1R parathyroid hormone receptor. Hypercalcemia and short-limbed dwarfism. Worked out NEJM 335: 708, 1996.a

HYPERCALCEMIA: Differential diagnosis for beginners. Review Postgrad. Med. 115: 69, 2004.

  • Hyperparathyroidism (primary or tertiary or familial hypocalciuric hypercalcemia or Jansen's)
  • Ectopic hPTH-like substance (i.e., from tumor, most often squamous cell carcinoma of lung, occasionally renal cell carcinoma or others). Now called PTH-related peptide (PTH-rP). Pseudohyperparathyroidism.
  • Vitamin D toxicity (ask about vitamin A and "dolomite" pills, too)
  • Lytic bone metastases
  • Plasma cell myeloma
  • Sarcoidosis (vitamin D activation by granulomas)
  • Milk-alkali syndrome
  • Thiazide diuretics (especially in new users or those with unrecognized parathyroid or Paget's disease)
  • * Williams microdeletion syndrome (supersensitive to vitamin D)

HYPOPARATHYROIDISM

    The most common cause is iatrogenic (following thyroid surgery).

      * Long-overdue, pathologists and surgeons are now working together to examine excised thyroid material intra-operatively to be sure that parathyroid was not taken, and if so, to replace it (Arch. Otol. 133: 1105, 2007).

    Next is autoimmunity (remember the syndrome with addisonism, ectodermal dysplasia, and mucosal candida? -- J. Clin. Endo. Metab. 88: 4602, 2003). In both familial and sporadic cases, the autoantigen is often CaSR (J. Clin. Inv. 97: 910, 1996; updates J. Clin. Endo. Metab. 89: 4484, 2004; J. Clin. Endo. Metab. 94: 4655, 2009). You also remember DiGeorge's syndrome.

    * Zebras: Kearns-Sayre / mitochondriopathy (J. Clin. Endo. Metab. 83: 125, 1998), Wilson's, Riedel's struma; X-linked agenesis syndrome (J. Clin. Inv. 115: 2822, 2005); various genetic syndromes (for example J. Clin. Endo. Metab. 91: 4587, 2007).

    Symptoms and signs of hypocalcemia begin with mental changes, circumoral paraesthesia, Chvostek's sign, Trousseau's sign, and progress to carpopedal spasm, convulsions, tetany. Check for cataracts, too; nobody knows why they tend to occur when ionized calcium is low.

      The diagnosis is confirmed by finding low serum calcium and high serum phosphate.

      * Treatment includes vitamin D and calcium gluconate cookies (lifelong.) Injectable parathormone is now becoming available (J. Clin. Endo. Metab. 88: 4214, 2003).

      By the way... there's plenty of vitamin D deficiency (low calcium, low phosphate) thanks to lack of sunlight (chosen lifestyles, veiling of women) and/or malnutrition (fad diets, poverty, malabsorption) and/or vitamin D resistance (genetic syndromes). Update on hypocalcemia: BMJ 336: 1298, 2008.

    PSEUDOHYPOPARATHYROIDISM

      Some curious disorders. In each, there is an inability to carry the parathyroid hormone receptor signal to the cell's machinery. (Proc. Nat. Acad. Sci. 95: 10038 & 11798 & 15475, 1998; Am. J. Med. Genet. 77: 261, 1998; J. Clin. End. Metab. 81: 1660, 1996).

      As you'd expect, serum calcium runs low, phosphate runs high, and (except in type II) urinary cAMP fails to rise in response to parathyroid hormone administration.

      In Pseudohypoparathyroidism TYPE IA, there is a mutation of a portion of the GNAS1 gene that codes for Gsα. There is a striking imprinting effect (Am. J. Hum. Genet. 68: 1283, 2001.)

        In kidney (PTH-receptor), thyroid (TSH receptor), ovary (FSH-LH receptors), pituitary (getting worked out), and elsewhere (growth hormone recetors: J. Clin. Endo. Metab. 88: 4070, 2003); only Mom's allele is expressed. In bone, both Mom and Dad's alleles are expressed.

        Hence, if you inherited a bad allele from your mother, you get resistance to parathyroid hormone (marked), plus some resistance to other endocrine hormones. Plus, you get the bony deformities ("Albright's hereditary osteodystrophy"), with short stature, short fingers, and a round face.

        If you inherited a bad allele from your father, you get ONLY the bony deformities ("pseudopseudohypoparathyroidism").

        * Certain bad alleles inherited from Dad produce the thankfully-rare progressive osseous heteroplasia, in which skin and muscle transform into bone (NEJM 346: 99 & 128, 2002 -- now distinguished from true "myositis ossificans").

      In Pseudohypoparathyroidism TYPE IB, the bones are formed normally. The kidney is resistant to the effects of parathyroid hormone and there is milder resistance to TSH as in type Ia. The mutated gene (* STX16 / syntaxin 16) is adjacent to the GNAS1 locus; it's recently been identified as a portion of the complex that's responsible for its being imprinted (J. Clin. Inv. 1255: 112, 2003). It can only be expressed if it is inherited from Mom.

      * In Pseudohypoparathyroidism TYPE IC, the alpha subunit is normal but there is the osteodystrophy. In the 1990's I predicted it was caused by a different allele at the GNAS1 locus and this has now been demonstrated (J. Clin. Endo. Metab. 87: 189, 2002; J. Ped. Endo. 19-S2: 635, 2006).

      In Pseudohypoparathyroidism TYPE II, there is resistance to the effects of parathyroid hormone in bone and kidney, and some bone deformities. However, the urinary cAMP response to PTH challenge is normal, and The GNAS1 locus is not involved (i.e., there's a problem with the signal distal to cAMP). The genetics remains obscure.

      * If you lack both copies of the real parathyroid hormone receptor, you die as a baby of a severe dyschondroplasia. Carriers are asymptomatic.

Child with pseudo-pseudo-hypoparathyroidism
Courtesy of Mary Fay MD

THYMUS

Thymus Exhibit
Virtual Pathology Museum
University of Connecticut

Thymus Histology
Ed's Histology Notes

    Originates from the third and (* ?) fourth pharyngeal pouches (* hence, a good location for an ectopic parathyroid gland.)

    Large in neonates, it starts to involute after puberty, and is usually just a mass of fat in older people.

    The cortex (many lymphocytes) and medulla (few lymphocytes) have as their basic structural unit an unusual stellate epithelial cell.

      * A few of these cells differentiate as keratinizing squamous pearls, or Hassall's corpuscles.

      You are already familiar with the severe underdevelopment of the gland in such illnesses as ataxia-telangiectasia, DiGeorge / Nezelof, and some (not all) forms of severe combined immunodeficiency. Usually these people lack good corticomedullary differentiation and Hassall's corpuscles, as well as lymphocytes.

      Thymic cysts are fairly common (3rd branchial pouch), but don't assume all cysts are benign -- for some reason, cysts often form near a thymic cancer (Hodgkin's, germinoma).

      * Ask a pathologist about the "myoid cells" in the medulla. They contain actin, myosin, and myoglobin. Maybe this has something to do with the whole myasthenia gravis connection.

{14760}      normal kid's thymus; a=cortex, b=medulla, c=vessel
{13958}      Hassall's corpuscles stained for keratin (this appears to be normal thyroid)

    * Stress lesions in the thymus are of interest to pathologists, and help us tell how long somebody was seriously sick. Before 12 hours, there are no changes. At 12-24 hours, you start seeing macrophages eating lymphocytes. At 24-48 hours, you start seeing a starry sky. Over 48 hours, the corticomedullary junction becomes blurry as the gland atrophies. After 72 hours, the gland is atrophic and there will be no further changes.

    FOLLICULAR HYPERPLASIA is said to present when there are large germinal follicles in the organ.

      Most folks do have a few tiny germinal follicles in the thymus gland. I'd ask you to reserve the term THYMIC FOLLICULAR HYPERPLASIA for situations in which the gland itself is oversized. This is common in folks with various autoimmune diseases (especially lupus and addisonism), and in early HIV infection.

      Patients with myasthenia gravis, an autoimmune diseases caused by anti-NMJ antibodies, also show thymic hyperplasia (unless it is removed or destroyed by a thymoma), and thymectomy is the best treatment for myasthenia gravis.

        * The less-common form of myasthenia gravis, caused by antibodies against muscle-specific kinase, is not helped by thymectomy (Brain 126: 2304, 2003).

        * True hyperplasia of the thymus is simply a gland that's oversized for the person's age. For some reason that no one understands, this is fairly common in adults who have been cured of a malignancy by chemotherapy.

    THYMOMA is a histologically-benign tumor of the epithelial cells of the thymus gland. There are often lymphocytes mixed in, but these are non-neoplastic.

      The gross appearance (i.e., whether or not the tumor invades the mediastinal structures) is most important for prognosis.

      The World Health Organization (1999) classification of thymomas is now standard, and predicts outcome quite well (Ann. Thor. Surg. 77: 183, 2004); one group thinks it's too complicated and a simplified system would work just as well in answering the real question (i.e., who should get chemo / radiation? Cancer 112: 2780, 2008).

        * From best-to-worst prognosis, they are:

          Type A: Spindle or oval epithelial cells, no atypia, no lymphocytes
          Type AB: Like A, but with some areas rich in lymphocytes
          Type B1: Areas that look like normal thymic cortex, and areas that look like normal thymic medulla
          Type B2: Plump epithelial cells with vesicular nuclei and big nucleoli; big perivascular spaces; palisades around vessels
          Type B3: Rounded / polygonal epithelial cells growing in sheets, only a few lymphocytes
          Type C: Obvious atypia, less recognizable as thymus. There are over a dozen variants described.

          Not classified yet... Fibrosing variant: Am. J. Clin. Path. 121: 867, 2004.

        A's can expect cures, AB's are usually cured (Ann. Thorac. Surg. 77: 1183, 2004). The rest are more dangerous, but the stage of the tumor at presentation is more important, and pathologists cannot distinguish the entities in type B very well: Chest 127: 755, 2005.

{13952}      thymoma, gross
{25653}      thymoma, gross
{13955}      thymic tumor, possibly Hodgkin's
{49097}      malignant thymoma, gross

Thymoma
Pittsburgh Pathology Cases

Thymoma
WebPath Case of the Week

Non-Invasive Thymoma
Pittsburgh Illustrated Case

      Among thymoma patients...

        Myasthenia gravis occurs in around 50% (* and around 30% of myasthenia gravis patients have a thymoma; thymomas express acetyl choline receptor epitope on their cells Lancet 339: 707, 1992; update on these thymomas Ann. Thor. Surg. 79: 219, 2005).

        Acquired "pure red cell aplasia" (stop putting out red cells, presumably autoimmune) occurs in around 20%

        Hypogammaglobulinemia occurs in a few percent and is called Good's syndrome (rare, but in the "diff" of nearly everything)

        * Thymoma series from M.D. Anderson Cancer 73: 2491, 1994 (not surprisingly, they're for chemotherapy....)

    Other thymus tumors:

      LYMPHOMAS (T-cell, of course), CARCINOIDS (aggressive, and likely to produce ACTH or other troublesome hormones: Am. J. Clin. Path. 114: 200, 2000; Ann. Thor. Surg. 74: 133, 2003; the histology does not predict behavior Chest 124: 141, 2003; spotting them on needle aspiration Arch. Path. Lab. Med. 130: 1612, 2006), * CARCINOMAS (i.e., obviously malignant on histopathology: Cancer 67: 1025, 1991), and * germinomas (seminomas -- check for positive staining for placental alkaline phosphatase -- , less often embryonal-cell carcinomas or choriocarcinomas) arise in the thymus.

      * Thymic TERATOMAS are relatively common.

      Primary thymic lymphoma
      Virginia
      Good pictures

      * There's a popular "five T's" mnemonic for anterior mediastinal masses:

      • Thymoma

      • Teratoma

      • Testicular-type cancer

      • T-cell or Hodgkin's lymphoma

      • Thyroid enlargement (i.e., substernal goiter)

      Carcinoid
      Mediastinum
      Pittsburgh Pathology Cases

      * Brian Piccolo, of "Brian's Song" fame, had a thymic embryonal-cell type carcinoma, as did football player Dan Turk.

      * "Status thymicolymphaticus" was an imaginary disease, dreamed up to explain SIDS and infanticide, for which several million newborns received radiation therapy. They are now at much increased risk for papillary carcinoma of the thyroid. (There's a lesson here -- self-deception is certain in the absence of proper controls.)

PINEAL ("the third eye"): Tumors of the pineal are troublesome because of their location. In children, pineal tumors are likely to produce sexual precocity.

    PINEALOMA, except for its location, looks exactly like a seminoma or dysgerminoma.

    Other germ-cell tumors occur in the pineal also, so you could see a pineal teratoma, a pineal choriocarcinoma, or any other. (I've seen all three.)

    PINEALOBLASTOMA (see above) resemble neuroblastomas and medulloblastomas.

    PINEOCYTOMAS are made up of cells like those in adult pineal. Both are aggressive cancers seen most often in children.

    GLIOMAS, etc., can occur in the pineal. Pineal tumors: Cancer 72: 870, 1993. Cysts: Neurology 41: 1034, 1991 (fooled me once).

{03998}      normal pineal gland, anatomy
{02815}      normal pineal gland, gross
{01223}      normal pineal gland
{01239}      normal pineal gland histology, with brain sand
{05219}      pineal cyst, gross
{01711}      pineal germinoma, gross

Pineocytoma
Pittsburgh Pathology Cases

* THE MELATONIN BUSINESS: Older review Am. Fam. Phys. 57(8): 1783, 1998.

    Since the stuff is dirt-cheap to make, occurs naturally, and isn't patentable, it's now widely available over the counter.

    If you believed everything you heard about melatonin, you'd be reading uncritically. What is clear is that its effects on insomnia and jetlag have impressed people far more than most "supplement" stuff.

    A meta-analysis found melatonin basically useless overall in sleep disorders, even jet lag and shiftwork disorder (for which it was once famous: BMJ 332: 385, 2006). Since the pineal often calcifies in older folks, and perhaps fails as a result, look forward to melatonin as a sleep aid especially in geriatrics. The most recent study showing an effect of the stuff showed it worked best on patients who don't secrete normal amount of melatonin metabolite, and that these were mostly older folks (Am. J. Med. 116: 91, 2004).

    There are some hopeful results in irritable bowel syndrome (Gut 54: 1353, 2005) and a non-yet-reproduced report of improvement in tardive dyskinesia (Arch. Gen. Psych. 58: 1049, 2001). An optimistic study in children (Clin. Ped. 42: 51, 2003) lacked controls. For old folks with "cognitive decline, mood, behavioral and sleep disturbances", melatonin seems to help as long as it's also given with bright light (JAMA 299: 2642, 2008; I couldn't help but wonder if the old folks weren't simply being given more attention, hence the benefit.)

    In the meantime, the stuff seems extremely safe, and I wouldn't fault you for wanting to experiment, assuming you give proper informed consent.

THE MAN

          A man said to the universe:
          "Sir, I exist!"

          "However," replied the universe,
          "That fact has not created in me
          A sense of obligation."

                  -- Stephen Crane

                    (1871-1900)

BIBLIOGRAPHY / FURTHER READING

PicoSearch
  Help

Visitors to www.pathguy.com
reset Jan. 30, 2005:

Ed at homeDrop by and meet Ed

Ed says, "This world would be a sorry place if people like me who call ourselves Christians didn't try to act as good as other good people ." Prayer Request

If you have a Second Life account, please visit my teammates and me at the Medical Examiner's office.

Teaching Pathology

Pathological Chess


Taser Video
83.4 MB
7:26 min